Worth reading
35Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Agreements reached under this partnership
Business Alliances3154MEDIUS HOLDINGS Co.,Ltd.
Alliance partner東邦薬品株式会社
Details of the alliance
- 1
Strengthening pharmaceutical and medical materials SPD functions in the Tokai region
- 2
Development of solutions for medical institutions
- 3
Development of next-generation advanced SPD functions and solutions for medical institutions
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
About the partner
Business DescriptionSale of prescription pharmaceuticals, diagnostic reagents and medical equipment, and development and provision of customer support systems, among other activities
LocationChuo-ku, Tokyo
Share capital¥300 million
| Item | Details |
|---|---|
| Name of alliance partner | 東邦薬品株式会社 |
| Alliance partner's business activities | Sale of prescription pharmaceuticals, diagnostic reagents and medical equipment, and development and provision of customer support systems, among other activities |
| Alliance partner's location | Chuo-ku, Tokyo |
| Alliance partner's capital | ¥300 million |
| Type of alliance | Business Alliances |
| Details of the alliance | Strengthening pharmaceutical and medical materials SPD functions in the Tokai region, Development of solutions for medical institutions, Development of next-generation advanced SPD functions and solutions for medical institutions |
Items this document does not state (17)
Alliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioOverview of the joint ventureOwnership ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionContract DateAlliance start dateShare Acquisition Date and Payment DateImpact on Business PerformanceChange in major shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To integrate 東邦薬品's pharmaceutical SPD functions with 協和医科器械's medical materials SPD functions and develop next-generation advanced SPD functions and solutions for medical institutions.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.